These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16498458)

  • 1. Targeting NF-kappaB in hematologic malignancies.
    Braun T; Carvalho G; Fabre C; Grosjean J; Fenaux P; Kroemer G
    Cell Death Differ; 2006 May; 13(5):748-58. PubMed ID: 16498458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappaB and IKK as therapeutic targets in cancer.
    Kim HJ; Hawke N; Baldwin AS
    Cell Death Differ; 2006 May; 13(5):738-47. PubMed ID: 16485028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies.
    Panwalkar A; Verstovsek S; Giles F
    Cancer; 2004 Apr; 100(8):1578-89. PubMed ID: 15073843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-κB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia.
    Breccia M; Alimena G
    Expert Opin Ther Targets; 2010 Nov; 14(11):1157-76. PubMed ID: 20858024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
    Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
    Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappaB in cancer--a friend turned foe.
    Ravi R; Bedi A
    Drug Resist Updat; 2004 Feb; 7(1):53-67. PubMed ID: 15072771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappaB as a therapeutic target in chronic lymphocytic leukemia.
    Lopez-Guerra M; Colomer D
    Expert Opin Ther Targets; 2010 Mar; 14(3):275-88. PubMed ID: 20148715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor-kappaB in development, prevention, and therapy of cancer.
    Van Waes C
    Clin Cancer Res; 2007 Feb; 13(4):1076-82. PubMed ID: 17317814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
    Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
    Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ubiquitin in NF-kappaB regulatory pathways.
    Skaug B; Jiang X; Chen ZJ
    Annu Rev Biochem; 2009; 78():769-96. PubMed ID: 19489733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
    Fan S; Meng Q; Laterra JJ; Rosen EM
    Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated NF-kappaB activity in haematological malignancies.
    Keutgens A; Robert I; Viatour P; Chariot A
    Biochem Pharmacol; 2006 Oct; 72(9):1069-80. PubMed ID: 16854381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia.
    Fabre C; Carvalho G; Tasdemir E; Braun T; Adès L; Grosjean J; Boehrer S; Métivier D; Souquère S; Pierron G; Fenaux P; Kroemer G
    Oncogene; 2007 Jun; 26(28):4071-83. PubMed ID: 17213804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.
    Park J; Ahn KS; Bae EK; Kim BS; Kim BK; Lee YY; Yoon SS
    Anticancer Drugs; 2008 Sep; 19(8):777-82. PubMed ID: 18690088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies.
    Fuchs O
    Curr Mol Pharmacol; 2010 Nov; 3(3):98-122. PubMed ID: 20594187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the transcription factor NF-kappaB.
    Schmid JA; Birbach A
    Cytokine Growth Factor Rev; 2008 Apr; 19(2):157-65. PubMed ID: 18308615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor-kappaB activation: from bench to bedside.
    Sethi G; Sung B; Aggarwal BB
    Exp Biol Med (Maywood); 2008 Jan; 233(1):21-31. PubMed ID: 18156302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
    Romagnoli M; Desplanques G; Maïga S; Legouill S; Dreano M; Bataille R; Barillé-Nion S
    Clin Cancer Res; 2007 Oct; 13(20):6010-8. PubMed ID: 17947462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-alpha induces transient resistance to Fas-induced apoptosis in eosinophilic acute myeloid leukemia cells.
    Qin Y; Auh S; Blokh L; Long C; Gagnon I; Hamann KJ
    Cell Mol Immunol; 2007 Feb; 4(1):43-52. PubMed ID: 17349210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.